WallStreetZenWallStreetZen

NASDAQ: IMRX
Immuneering Corp Stock Ownership - Who owns Immuneering?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Immuneering Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Benjamin J. ZeskindPRESIDENT AND CEO2025-07-027,015$3.53
$24.79kBuy
Benjamin J. ZeskindPRESIDENT AND CEO2025-07-012,985$3.38
$10.09kBuy
Thomas J. SchallDirector2025-06-279,500$3.66
$34.79kBuy
Brett Matthew HallCHIEF SCIENTIFIC OFFICER2025-06-236,007$2.43
$14.60kBuy
Harold Eugene BrakewoodChief Business Officer2025-06-201,900$2.53
$4.81kBuy
Brett Matthew HallCHIEF SCIENTIFIC OFFICER2025-06-207,415$2.70
$20.02kBuy
Benjamin J. ZeskindPRESIDENT AND CEO2025-06-1821,000$2.39
$50.15kBuy
Peter FeinbergDirector2025-06-1825,000$2.53
$63.18kBuy
Thomas J. SchallDirector2025-06-1740,485$2.21
$89.27kBuy
Mallory MoralesChief Accounting Officer2024-09-154,458$1.62
$7.24kBuy

1 of 1

IMRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMRX insiders and whales buy or sell their stock.

IMRX Shareholders

What type of owners hold Immuneering Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cormorant Asset Management LP19.73%7,099,637$24.49MInsider
Benjamin J. Zeskind10.43%3,752,706$12.95MInsider
Peter Feinberg4.06%1,460,798$5.04MInsider
Robert J. Carpenter3.19%1,148,839$3.96MInsider
Vanguard Group Inc2.94%1,056,922$3.65MInstitution
Marshall Wace LLP2.25%807,969$2.79MInstitution
Price T Rowe Associates Inc1.83%659,009$2.27MInstitution
Morgan Stanley1.30%467,226$1.61MInstitution
Brett Matthew Hall1.00%359,318$1.24MInsider
Blackrock Inc0.88%316,530$1.09MInstitution

1 of 3

IMRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMRX12.50%38.91%Net BuyingNet Buying
NKTX63.53%36.47%Net SellingNet Selling
KRRO25.62%74.38%Net Buying
SGMO22.54%13.89%Net SellingNet Selling
PLX5.67%94.33%
View Top Biotech Stocks

Immuneering Stock Ownership FAQ

Who owns Immuneering?

Immuneering (NASDAQ: IMRX) is owned by 12.50% institutional shareholders, 38.91% Immuneering insiders, and 48.58% retail investors. Cormorant Asset Management LP is the largest individual Immuneering shareholder, owning 7.10M shares representing 19.73% of the company. Cormorant Asset Management LP's Immuneering shares are currently valued at $24.49M.

If you're new to stock investing, here's how to buy Immuneering stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.